Kiromic Biopharma, Inc. Business Finance Contracts & Agreements
53 Contracts & Agreements
- Exchange Agreements (6 contracts)
- Investor Rights Agreements (1)
- Note Agreements (28)
- Purchase Agreements (2)
- Stock Agreements (3)
- Underwriting Agreements (4)
- Warrant Agreements (9)
- Form of Exchange Agreement dated as of November 1, 2024 between the Company and the holder of the Exchange Notes (Filed With SEC on November 4, 2024)
- Form of Exchange Agreement dated as of September 27, 2024 between the Company and the holder of the Exchange Securities (Filed With SEC on September 30, 2024)
- 25% Senior Secured Convertible Promissory Note, dated August 1, 2024 (Filed With SEC on August 5, 2024)
- First Amendment to 25% Senior Secured Convertible Promissory Note (Filed With SEC on July 10, 2024)
- 25% Senior Secured Convertible Promissory Note (Filed With SEC on July 10, 2024)
- 25% Senior Secured Convertible Promissory Note (Filed With SEC on June 27, 2024)
- Exchange Agreement dated as of June 21, 2024 between the Company and the Holder (Filed With SEC on June 27, 2024)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on June 7, 2024)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on May 6, 2024)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on April 5, 2024)
- Form of Exchange Agreement dated as of March 28, 2024 between the Company and the holder of the Exchange Securities (Filed With SEC on April 2, 2024)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on March 11, 2024)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on February 14, 2024)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on January 11, 2024)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on December 15, 2023)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on November 6, 2023)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on October 2, 2023)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on August 29, 2023)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on July 27, 2023)
- Form of Exchange Agreement dated as of July 18, 2023 between the Company and the holder of the Exchange Securities (Filed With SEC on July 19, 2023)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on June 27, 2023)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on May 30, 2023)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on April 28, 2023)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on March 31, 2023)
- Form of Exchange Agreement dated as of March 28, 2023 between the Company and the holder of the Exchange Securities (Filed With SEC on March 31, 2023)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on February 27, 2023)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on January 26, 2023)
- Form of Note Purchase Agreement (Filed With SEC on January 26, 2023)
- Form of the Amended and Restated 25% Senior Secured Convertible Promissory Note (Filed With SEC on December 16, 2022)
- Amended Stipulation of Settlement and Mutual Release, dated October 27, 2022, by and among Kiromic Biopharma, Inc., Sabby Volatility Warrant Master Fund Ltd. and other parties (Filed With SEC on November 2, 2022)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on October 27, 2022)
- Standby Equity Purchase Agreement, dated October 13, 2022, by and between Kiromic Biopharma, Inc. and YA II PN, Ltd (Filed With SEC on October 19, 2022)
- Form of the Subordinated Convertible Promissory Note (Filed With SEC on October 14, 2022)
- Stipulation of Settlement and Mutual Release, dated October 10, 2022, by and among Kiromic Biopharma, Inc., Sabby Volatility Warrant Master Fund Ltd. and other parties (Filed With SEC on October 14, 2022)
- Form of Representatives Warrant (Filed With SEC on July 13, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on July 13, 2022)
- Form of Warrant Agent Agreement (Filed With SEC on July 13, 2022)
- Form of Common Stock Warrants (Filed With SEC on July 13, 2022)
- Form of Underwriting Agreement (Filed With SEC on July 13, 2022)
- Form of Representatives Warrant (Filed With SEC on June 25, 2021)
